(Q34224777)

31 July 2017

1 reference

title

Vascular effects of hormones (English)

1 reference

31 July 2017

Collins P

1

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

38

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

45-50; discussion 50-1

1 reference

Menopause and the risk of coronary heart disease in women

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Estrogen hits the surface

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Estrogen acutely increases peripheral blood flow in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Short-term estrogen administration ameliorates dobutamine-induced myocardial ischemia in postmenopausal women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Oestrogen improves exercise-induced myocardial ischaemia in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Postmenopausal hormone therapy and coronary heart disease: clinical implications of recent randomized trial results

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

The association of hypotestosteronemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Effect of acute testosterone on myocardial ischemia in men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900197-3

7 January 2021

10.1016/S0378-5122(00)00197-3

Identifiers

DOI

1 reference

31 July 2017

1 reference